Significance of the lupus anticoagulant.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000502:physiology; D001780:Blood Coagulation Tests; D004247:DNA / Q000276:immunology; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007616:Kaolin; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D010314:Partial Thromboplastin Time; D010743:Phospholipids / Q000037:antagonists & inhibitors / Q000276:immunology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011517:Prothrombin Time; D013927:Thrombosis / Q000209:etiology; D014841:von Willebrand Factor / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D001779:Blood Coagulation Factors; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids; D014841:von Willebrand Factor; D007616:Kaolin; D005169:Factor VIII; D004247:DNA; D001379:Azathioprine